Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50


Detection of Significant Association Between Variants in Cannabinoid Receptor 1 Gene (CNR1) and Personality in African-American Population.

Yao Y, Xu Y, Zhao J, Ma Y, Su K, Yuan W, Ma JZ, Payne TJ, Li MD.

Front Genet. 2018 Jun 14;9:199. doi: 10.3389/fgene.2018.00199. eCollection 2018.


Sacred Maya incense, copal (Protium copal - Burseraceae), has antianxiety effects in animal models.

Merali Z, Cayer C, Kent P, Liu R, Cal V, Harris CS, Arnason JT.

J Ethnopharmacol. 2018 Apr 24;216:63-70. doi: 10.1016/j.jep.2018.01.027. Epub 2018 Feb 3.


Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Amare AT, Schubert KO, Baune BT.

EPMA J. 2017 Sep 5;8(3):211-227. doi: 10.1007/s13167-017-0112-8. eCollection 2017 Sep. Review.


Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum.

Mandolesi G, Bullitta S, Fresegna D, Gentile A, De Vito F, Dolcetti E, Rizzo FR, Strimpakos G, Centonze D, Musella A.

Neurobiol Dis. 2017 Dec;108:45-53. doi: 10.1016/j.nbd.2017.07.019. Epub 2017 Jul 27.


[Role of cannabinoid receptor 1-mediated synaptic plasticity in neuropathic pain and associated depression].

Pan W, Wang X, Zhang G, Yang J.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Mar 28;42(3):340-345. doi: 10.11817/j.issn.1672-7347.2017.03.017. Chinese.


A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.

D'Addario C, Micale V, Di Bartolomeo M, Stark T, Pucci M, Sulcova A, Palazzo M, Babinska Z, Cremaschi L, Drago F, Carlo Altamura A, Maccarrone M, Dell'Osso B.

Schizophr Res. 2017 Oct;188:132-140. doi: 10.1016/j.schres.2017.01.022. Epub 2017 Jan 17.


Variants in the CNR1 gene predispose to headache with nausea in the presence of life stress.

Juhasz G, Csepany E, Magyar M, Edes AE, Eszlari N, Hullam G, Antal P, Kokonyei G, Anderson IM, Deakin JF, Bagdy G.

Genes Brain Behav. 2017 Mar;16(3):384-393. doi: 10.1111/gbb.12352. Epub 2016 Nov 23.


Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.

Gentile A, Fresegna D, Musella A, Sepman H, Bullitta S, De Vito F, Fantozzi R, Usiello A, Maccarrone M, Mercuri NB, Lutz B, Mandolesi G, Centonze D.

J Neuroinflammation. 2016 Sep 2;13(1):231. doi: 10.1186/s12974-016-0682-8.


The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.

Gueye AB, Pryslawsky Y, Trigo JM, Poulia N, Delis F, Antoniou K, Loureiro M, Laviolette SR, Vemuri K, Makriyannis A, Le Foll B.

Int J Neuropsychopharmacol. 2016 Dec 30;19(12). pii: pyw068. doi: 10.1093/ijnp/pyw068. Print 2016 Dec.


A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro.

Veeraraghavan P, Dekanic A, Nistri A.

Neuroscience. 2016 Oct 1;333:214-28. doi: 10.1016/j.neuroscience.2016.07.021. Epub 2016 Jul 20.


Presynaptic Spike Timing-Dependent Long-Term Depression in the Mouse Hippocampus.

Andrade-Talavera Y, Duque-Feria P, Paulsen O, Rodríguez-Moreno A.

Cereb Cortex. 2016 Aug;26(8):3637-3654. doi: 10.1093/cercor/bhw172. Epub 2016 Jun 9.


Pharmacological characterization of emerging synthetic cannabinoids in HEK293T cells and hippocampal neurons.

Costain WJ, Tauskela JS, Rasquinha I, Comas T, Hewitt M, Marleau V, Soo EC.

Eur J Pharmacol. 2016 Sep 5;786:234-245. doi: 10.1016/j.ejphar.2016.05.040. Epub 2016 May 31.


Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study.

Maple KE, McDaniel KA, Shollenbarger SG, Lisdahl KM.

Am J Drug Alcohol Abuse. 2016 Jul;42(4):431-40. doi: 10.3109/00952990.2016.1141913. Epub 2016 Apr 13.


Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice.

Bowers ME, Ressler KJ.

Behav Brain Res. 2016 Mar 1;300:65-9. doi: 10.1016/j.bbr.2015.12.005. Epub 2015 Dec 9.


A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients.

Icick R, Peoc'h K, Karsinti E, Ksouda K, Hajj A, Bloch V, Prince N, Mouly S, Bellivier F, Lépine JP, Laplanche JL, Vorspan F.

Am J Addict. 2015 Oct;24(7):613-20. doi: 10.1111/ajad.12273. Epub 2015 Sep 1.


[The endocannabinoid system role in the pathogenesis of obesity and depression].

Zdanowicz A, Kaźmierczak W, Wierzbiński P.

Pol Merkur Lekarski. 2015 Jul;39(229):61-6. Review. Polish.


Diacylglycerol Lipase α Knockout Mice Demonstrate Metabolic and Behavioral Phenotypes Similar to Those of Cannabinoid Receptor 1 Knockout Mice.

Powell DR, Gay JP, Wilganowski N, Doree D, Savelieva KV, Lanthorn TH, Read R, Vogel P, Hansen GM, Brommage R, Ding ZM, Desai U, Zambrowicz B.

Front Endocrinol (Lausanne). 2015 Jun 2;6:86. doi: 10.3389/fendo.2015.00086. eCollection 2015.


An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity.

Lovelace JW, Corches A, Vieira PA, Hiroto AS, Mackie K, Korzus E.

Neuropharmacology. 2015 Dec;99:242-55. doi: 10.1016/j.neuropharm.2015.04.034. Epub 2015 May 13.


CB1 receptors modulate affective behaviour induced by neuropathic pain.

Rácz I, Nent E, Erxlebe E, Zimmer A.

Brain Res Bull. 2015 May;114:42-8. doi: 10.1016/j.brainresbull.2015.03.005. Epub 2015 Apr 8.


Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus.

Guggenhuber S, Alpar A, Chen R, Schmitz N, Wickert M, Mattheus T, Harasta AE, Purrio M, Kaiser N, Elphick MR, Monory K, Kilb W, Luhmann HJ, Harkany T, Lutz B, Klugmann M.

Brain Struct Funct. 2016 May;221(4):2061-74. doi: 10.1007/s00429-015-1027-6. Epub 2015 Mar 15.


Supplemental Content

Loading ...
Support Center